IGC PHARMA INC (IGC) Stock Fundamental Analysis

USA • NYSE Arca • NYSEARCA:IGC • US45408X3089

0.27 USD
-0.01 (-2.63%)
At close: Jan 30, 2026
0.2776 USD
+0.01 (+2.81%)
After Hours: 1/30/2026, 8:04:00 PM
Fundamental Rating

1

Overall IGC gets a fundamental rating of 1 out of 10. We evaluated IGC against 190 industry peers in the Pharmaceuticals industry. Both the profitability and financial health of IGC have multiple concerns. IGC has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year IGC has reported negative net income.
  • In the past year IGC has reported a negative cash flow from operations.
  • In the past 5 years IGC always reported negative net income.
  • IGC had a negative operating cash flow in each of the past 5 years.
IGC Yearly Net Income VS EBIT VS OCF VS FCFIGC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -5M -10M -15M

1.2 Ratios

  • The Return On Assets of IGC (-66.16%) is worse than 70.00% of its industry peers.
  • IGC has a Return On Equity (-79.66%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -66.16%
ROE -79.66%
ROIC N/A
ROA(3y)-93.23%
ROA(5y)-72.05%
ROE(3y)-122.42%
ROE(5y)-91.4%
ROIC(3y)N/A
ROIC(5y)N/A
IGC Yearly ROA, ROE, ROICIGC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -50 -100 -150

1.3 Margins

  • The Gross Margin of IGC (46.20%) is better than 63.68% of its industry peers.
  • In the last couple of years the Gross Margin of IGC has grown nicely.
  • IGC does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 46.2%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.84%
GM growth 5Y75.22%
IGC Yearly Profit, Operating, Gross MarginsIGC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -1K -2K -3K

1

2. Health

2.1 Basic Checks

  • IGC does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for IGC has been increased compared to 1 year ago.
  • The number of shares outstanding for IGC has been increased compared to 5 years ago.
  • Compared to 1 year ago, IGC has a worse debt to assets ratio.
IGC Yearly Shares OutstandingIGC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
IGC Yearly Total Debt VS Total AssetsIGC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M

2.2 Solvency

  • Based on the Altman-Z score of -10.78, we must say that IGC is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -10.78, IGC is doing worse than 73.68% of the companies in the same industry.
  • A Debt/Equity ratio of 0.02 indicates that IGC is not too dependend on debt financing.
  • The Debt to Equity ratio of IGC (0.02) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Altman-Z -10.78
ROIC/WACCN/A
WACC9.41%
IGC Yearly LT Debt VS Equity VS FCFIGC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M -10M 20M 30M

2.3 Liquidity

  • A Current Ratio of 1.32 indicates that IGC should not have too much problems paying its short term obligations.
  • IGC has a Current ratio of 1.32. This is in the lower half of the industry: IGC underperforms 75.26% of its industry peers.
  • A Quick Ratio of 0.89 indicates that IGC may have some problems paying its short term obligations.
  • IGC has a worse Quick ratio (0.89) than 80.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.32
Quick Ratio 0.89
IGC Yearly Current Assets VS Current LiabilitesIGC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M

3

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 58.49% over the past year.
  • The Revenue has decreased by -6.51% in the past year.
  • The Revenue for IGC have been decreasing by -20.77% on average. This is quite bad
EPS 1Y (TTM)58.49%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%11.06%
Revenue 1Y (TTM)-6.51%
Revenue growth 3Y47.02%
Revenue growth 5Y-20.77%
Sales Q2Q%-53.64%

3.2 Future

  • The Earnings Per Share is expected to grow by 10.20% on average over the next years. This is quite good.
  • Based on estimates for the next years, IGC will show a quite strong growth in Revenue. The Revenue will grow by 9.74% on average per year.
EPS Next Y30.18%
EPS Next 2Y10.2%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year4.61%
Revenue Next 2Y9.74%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
IGC Yearly Revenue VS EstimatesIGC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2M 4M 6M
IGC Yearly EPS VS EstimatesIGC Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 -0.05 -0.1 -0.15 -0.2

0

4. Valuation

4.1 Price/Earnings Ratio

  • IGC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for IGC. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
IGC Price Earnings VS Forward Price EarningsIGC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
IGC Per share dataIGC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 -0.05

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y10.2%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

  • IGC does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

IGC PHARMA INC / IGC FAQ

What is the fundamental rating for IGC stock?

ChartMill assigns a fundamental rating of 1 / 10 to IGC.


What is the valuation status of IGC PHARMA INC (IGC) stock?

ChartMill assigns a valuation rating of 0 / 10 to IGC PHARMA INC (IGC). This can be considered as Overvalued.


How profitable is IGC PHARMA INC (IGC) stock?

IGC PHARMA INC (IGC) has a profitability rating of 1 / 10.


Can you provide the financial health for IGC stock?

The financial health rating of IGC PHARMA INC (IGC) is 1 / 10.